Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Healthcare Medical Devices
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Recent & Breaking News (NYSE:ABT)

Abbott Laboratories Deadline Alert

Newsfile September 18, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abbott Laboratories - ABT

Newsfile September 17, 2022

ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT

PR Newswire September 17, 2022

Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

PR Newswire September 17, 2022

ABBOTT LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT

PR Newswire September 16, 2022

RM LAW Announces Class Action Lawsuit Against Abbott Laboratories.

PR Newswire September 16, 2022

Abbott Laboratories Deadline Alert

Newsfile September 16, 2022

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT

Newsfile September 16, 2022

ABT SHAREHOLDER ALERT: Jakubowitz Law Reminds Abbott Shareholders of a Lead Plaintiff Deadline of October 31, 2022

PR Newswire September 16, 2022

Abbott Class Action: Levi & Korsinsky Reminds Abbott Laboratories Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 31, 2022 - ABT

Newsfile September 15, 2022

Abbott Declares 395th Consecutive Quarterly Dividend

PR Newswire September 15, 2022

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Established in Securities Fraud Class Action

Newsfile September 15, 2022

ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire September 15, 2022

ABBOTT LABORATORIES (ABT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Abbott Laboratories (ABT)

Newsfile September 15, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 31, 2022 in Abbott Lawsuit - ABT

Newsfile September 14, 2022

Abbott Laboratories Deadline Alert

Newsfile September 14, 2022

ROSEN, A TOP RANKED FIRM, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABT

Newsfile September 14, 2022

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Abbott Laboratories of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 31, 2022 - (NYSE: ABT)

PR Newswire September 14, 2022

ABT LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Abbott Laboratories

Newsfile September 13, 2022

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed

Newsfile September 13, 2022